Apaluside 60 Tablet is utilized in the management of Prostate Cancer. The specific applications of Apaluside 60 Tablet are outlined below:
• Management of Prostate Cancer: Apaluside 60 Tablet is employed in the treatment of prostate cancer, particularly non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer, by inhibiting androgen receptors, which aids in slowing or halting the proliferation of cancer cells.
APALUSIDE
| MRP | : |
|
| Price | : | ₹30,000.00 |
| You Save | : | ₹7,500.00 (20%) |
1 Bottle 120 Tablet
Apaluside 60 Tablet is an anti-androgen medication utilized for treating prostate cancer. Prostate cancer originates in the cells of the prostate gland in men. Symptoms may encompass difficulties in urination, pain, numbness, and more. Apaluside 60 Tablet is indicated for metastatic castration-sensitive prostate cancer as well as non-metastatic castration-resistant prostate cancer.
This medication contains Apalutamide, which is classified as an androgen inhibitor. It functions by blocking the production of testosterone, thereby halting the growth and dissemination of cancer.
Potential side effects of Apaluside 60 Tablet include fatigue, headaches, diarrhea, muscle aches, hot flashes, decreased appetite, and skin rashes. Typically, these side effects resolve without requiring medical intervention. It is important to take Apaluside 60 Tablet according to your doctor’s instructions.
If you have an allergy to Apaluside 60 Tablet, you should avoid using it. Notify your doctor prior to taking this medication if you have any existing conditions or a history of liver or kidney disease, cardiovascular issues such as myocardial ischemia, or seizures. Apaluside 60 Tablet is not advised for children, as its safety and effectiveness have not been established in this population. This medication is exclusively intended for male patients.

